Nancy Fairchild Net Worth

The estimated Net Worth of Nancy Fairchild is at least $2.23 Milion dollars as of 5 August 2020. Ms. Fairchild owns over 24,283 units of Luminex Corp stock worth over $1,251,298 and over the last 10 years she sold LMNX stock worth over $975,205. In addition, she makes $0 as Senior Vice President - Human Resources at Luminex Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Fairchild LMNX stock SEC Form 4 insiders trading

Nancy has made over 5 trades of the Luminex Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 24,283 units of LMNX stock worth $975,205 on 5 August 2020.

The largest trade she's ever made was exercising 69,282 units of Luminex Corp stock on 21 July 2020 worth over $1,284,488. On average, Nancy trades about 8,267 units every 1 days since 2015. As of 5 August 2020 she still owns at least 33,828 units of Luminex Corp stock.

You can see the complete history of Ms. Fairchild stock trades at the bottom of the page.

Nancy Fairchild biography

Nancy M. Fairchild serves as Senior Vice President - Human Resources of the Company. Ms. Fairchild joined the Company as Senior Director, Human Resources in March 2010. She was promoted to Vice President, Human Resources in August 2012 and to Senior Vice President, Human Resources in January 2015. Prior to joining the Company, Ms. Fairchild served from 2006 to 2010 as Chief Administrative Officer and Vice President of Human Resources and Organizational Development for the Electric Reliability Council of Texas which provides the energy grid services for Texas. In this role she managed Strategic Planning, Project Management, Facilities and Human Resources. Earlier in her career, she served as Vice President, Human Resources for Esoterix, Inc., an international healthcare company specializing in laboratory services, from 2001 to 2006, the Senior Vice President of Human Resources for Southern Union Company, a large natural gas conglomerate, from 1989 to 2001, and President of EnergyWorX, a training subsidiary, from 1996 to 2000. Ms. Fairchild is currently a member of the Board of Directors and Chair of the Audit Committee for Workforce Solutions, a local workforce development board in Texas, representing the biotech sector. She graduated with highest honors from Texas State University with a B.S. degree in Math Education and an M.S. degree in Counseling.

How old is Nancy Fairchild?

Nancy Fairchild is 66, she's been the Senior Vice President - Human Resources of Luminex Corp since 2015. There are 3 older and 10 younger executives at Luminex Corp. The oldest executive at Luminex Corp is Thomas Erickson, 69, who is the Independent Director.

Insiders trading at Luminex Corp

Over the last 21 years, insiders at Luminex Corp have traded over $55,627,864 worth of Luminex Corp stock and bought 685,936 units worth $10,423,148 . The most active insiders traders include G Walter Ii Loewenbaum, Douglas C Bryant a Laurence E Hirsch. On average, Luminex Corp executives and independent directors trade stock every 26 days with the average trade being worth of $888,944. The most recent stock trade was executed by Harriss T Currie on 1 March 2021, trading 5,325 units of LMNX stock currently worth $97,235.

What does Luminex Corp do?

The mission of Luminex is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. The Company offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. Luminex accelerates reliable answers while simplifying complexity and deliver certainty with a seamless experience.

Complete history of Ms. Fairchild stock trades at Luminex Corp

Luminex Corp executives and stock owners

Luminex Corp executives and other stock owners filed with the SEC include:

• Nachum Shamir,
  President, Chief Executive Officer, Director
• Harriss Currie,
  Chief Financial Officer, Senior Vice President - Finance, Treasurer
• Richard Rew,
  Senior Vice President, General Counsel and Corporate Secretary
• Todd Bennett,
  Senior Vice President - Global Sales and Customer Operations
• Randall Myers,
  Senior Vice President - Global Manufacturing and Quality
• Kenneth Samet,
  Independent Director
• Kevin McNamara,
  Independent Director
• Jimmy Kever,
  Independent Director
• Edward Ogunro,
  Lead Independent Director
• Thomas Erickson,
  Independent Director
• Stephen Eck,
  Independent Director
• Dijuana Lewis,
  Independent Director
• Eric Shapiro,
  Senior Vice President - Global Marketing
• Nancy Fairchild,
  Senior Vice President - Human Resources
• Chuck Collins,
  Senior Vice President - Research and Development
• Robert J Cresci,
  Director
• Tadd S. Lazarus,
  SVP, Chief Medical Officer
• Jay B Johnston,
  Director
• Russell S Bradley,
  VP, Strategic Planning and Bus
• G Walter Ii Loewenbaum,
  Director
• Jim D Kever,
  Director
• Gregory J Gosch,
  Vice President - Marketing
• Charles J. Collins,
  SR VP, R&D - US
• John C Carrano,
  VP, Research & Development
• J Stark Phd Thompson,
  Director
• Douglas C Bryant,
  EVP, Chief Operating Officer
• James W Jacobson,
  VP, Research & Development
• Oliver H Meek,
  VP, Manufacturing
• Randel S Martin,
  VP, Marketing/Sales
• Kristi M Richburg,
  Controller
• G Walter Ii Loewenbaum,
  Director
• C Thomas Caskey,
  Director
• Laurence E Hirsch,
  Director
• Fred C Jr Goad,
  Director
• Jeremy K Bridge Cook,
  VP, Luminex Molecular Diagn
• Michael F Pintek,
  SVP Operations
• Patrick J Balthrop,
  President, Chief Exec. Officer
• Timothy R Dehne,
  VP, Systems R&D
• David S Reiter,
  General Counsel & Secretary
• Gerard Vaillant,
  Director